SG Americas Securities’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.8M Buy
97,275
+51,201
+111% +$12.8M 0.02% 509
2025
Q4
$11.1M Sell
46,074
-10,027
-18% -$2.56M 0.01% 725
2025
Q3
$15.4M Buy
56,101
+47,758
+572% +$13M 0.05% 244
2025
Q2
$2.15M Buy
8,343
+3,576
+75% +$853K 0.01% 738
2025
Q1
$1.07M Sell
4,767
-14,333
-75% -$3.35M ﹤0.01% 1128
2024
Q4
$4.37M Buy
19,100
+13,974
+273% +$3.36M 0.02% 378
2024
Q3
$1.25M Sell
5,126
-21,591
-81% -$4.82M ﹤0.01% 912
2024
Q2
$5.11M Buy
26,717
+7,092
+36% +$1.44M 0.03% 537
2024
Q1
$3.89M Buy
19,625
+13,316
+211% +$2.44M 0.02% 635
2023
Q4
$1.08M Sell
6,309
-17,197
-73% -$2.64M 0.01% 983
2023
Q3
$3.48M Sell
23,506
-7,810
-25% -$1.41M 0.04% 440
2023
Q2
$6.84M Buy
+31,316
New +$6.98M 0.05% 274
2023
Q1
Sell
-2,074
Closed -$432K 3509
2022
Q4
$432K Sell
2,074
-6,659
-76% -$1.46M 0.01% 1656
2022
Q3
$1.91M Sell
8,733
-5,946
-41% -$1.35M 0.02% 607
2022
Q2
$3.08M Buy
14,679
+11,189
+321% +$2.38M 0.03% 514
2022
Q1
$846K Sell
3,490
-11,198
-76% -$2.71M 0.01% 1547
2021
Q4
$3.83M Sell
14,688
-13,674
-48% -$3.55M 0.02% 623
2021
Q3
$7.47M Buy
28,362
+12,523
+79% +$3.42M 0.04% 368
2021
Q2
$3.9M Sell
15,839
-36
-0.2% -$7.57K 0.02% 722
2021
Q1
$3.08M Buy
15,875
+179
+1% +$35.9K 0.02% 763
2020
Q4
$3.34M Sell
15,696
-215
-1% -$42.9K 0.02% 751
2020
Q3
$2.73M Buy
15,911
+6,515
+69% +$1.2M 0.02% 580
2020
Q2
$1.8M Sell
9,396
-3,579
-28% -$586K 0.02% 902
2020
Q1
$1.91M Buy
12,975
+7,140
+122% +$1.14M 0.02% 830
2019
Q4
$904K Sell
5,835
-20,352
-78% -$2.93M 0.01% 1337
2019
Q3
$3.54M Sell
26,187
-18,280
-41% -$2.39M 0.03% 607
2019
Q2
$5.43M Buy
44,467
+14,580
+49% +$1.62M 0.04% 501
2019
Q1
$3.11M Buy
29,887
+11,556
+63% +$1.19M 0.03% 623
2018
Q4
$2.09M Sell
18,331
-15,589
-46% -$1.67M 0.02% 852
2018
Q3
$3.91M Buy
33,920
+18,872
+125% +$2.07M 0.03% 657
2018
Q2
$1.56M Sell
15,048
-2,003
-12% -$203K 0.01% 1092
2018
Q1
$1.68M Sell
17,051
-14,072
-45% -$1.33M 0.01% 984
2017
Q4
$2.64M Buy
31,123
+18,307
+143% +$1.51M 0.02% 706
2017
Q3
$986K Sell
12,816
-19,521
-60% -$1.49M 0.01% 1277
2017
Q2
$2.52M Sell
32,337
-35,297
-52% -$2.53M 0.02% 752
2017
Q1
$4.87M Buy
67,634
+53,728
+386% +$3.71M 0.04% 399
2016
Q4
$863K Sell
13,906
-74,407
-84% -$4.56M 0.01% 1386
2016
Q3
$5.72M Sell
88,313
-6,482
-7% -$431K 0.06% 305
2016
Q2
$5.99M Buy
94,795
+16,258
+21% +$958K 0.04% 346
2016
Q1
$4.54M Buy
78,537
+41,375
+111% +$2.34M 0.03% 422
2015
Q4
$2M Buy
37,162
+32,611
+717% +$1.84M 0.01% 709
2015
Q3
$232K Sell
4,551
-41,032
-90% -$2.21M ﹤0.01% 1361
2015
Q2
$2.57M Buy
45,583
+18,813
+70% +$1.19M 0.02% 608
2015
Q1
$1.92M Sell
26,770
-12,942
-33% -$841K 0.01% 819
2014
Q4
$2.23M Sell
39,712
-521
-1% -$27.2K 0.01% 929
2014
Q3
$1.98M Sell
40,233
-35,788
-47% -$1.82M 0.01% 883
2014
Q2
$3.85M Buy
76,021
+58,969
+346% +$2.92M 0.02% 689
2014
Q1
$762K Sell
17,052
-67,173
-80% -$3.02M ﹤0.01% 1257
2013
Q4
$3.96M Buy
84,225
+9,972
+13% +$505K 0.02% 736
2013
Q3
$3.92M Buy
74,253
+44,110
+146% +$2.14M 0.02% 691
2013
Q2
$1.36M Buy
+30,143
New +$1.43M 0.01% 901

Other funds holding RMD

SG Americas Securities's RMD Position: Q1 2026 in Review

SG Americas Securities increased its ResMed (RMD) stake by 111% in Q1 2026, buying an estimated $12.8M and bringing the position to 97,275 shares worth $21.8M. The position accounts for 0.02% of the portfolio, ranked #509.

SG Americas Securities first reported a position in RMD in Q2 2013 and has held it in 51 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • SG Americas Securities held 97,275 shares of ResMed worth $21.8M as of Q1 2026.
  • SG Americas Securities bought 51,201 ResMed shares in Q1 2026, an estimated $12.8M.
  • ResMed made up 0.02% of SG Americas Securities's portfolio in Q1 2026, its #509 holding.
  • SG Americas Securities first reported a position in ResMed in Q2 2013 and has held it in 51 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.